State Street’s IGM Biosciences IGMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $85K | Sell |
75,913
-417,785
| -85% | -$468K | ﹤0.01% | 4005 |
|
|
2025
Q1 | $568K | Buy |
493,698
+34,247
| +7% | +$39.4K | ﹤0.01% | 3567 |
|
|
2024
Q4 | $2.81M | Sell |
459,451
-10,339
| -2% | -$63.2K | ﹤0.01% | 3204 |
|
|
2024
Q3 | $7.77M | Buy |
469,790
+12,174
| +3% | +$201K | ﹤0.01% | 2751 |
|
|
2024
Q2 | $3.14M | Buy |
457,616
+138,347
| +43% | +$950K | ﹤0.01% | 3125 |
|
|
2024
Q1 | $3.08M | Buy |
319,269
+11,801
| +4% | +$114K | ﹤0.01% | 3121 |
|
|
2023
Q4 | $2.56M | Buy |
307,468
+18,371
| +6% | +$153K | ﹤0.01% | 3232 |
|
|
2023
Q3 | $2.41M | Buy |
289,097
+27,848
| +11% | +$233K | ﹤0.01% | 3249 |
|
|
2023
Q2 | $2.41M | Buy |
261,249
+31,443
| +14% | +$290K | ﹤0.01% | 3327 |
|
|
2023
Q1 | $3.16M | Buy |
229,806
+3,651
| +2% | +$50.2K | ﹤0.01% | 3161 |
|
|
2022
Q4 | $3.85M | Buy |
226,155
+4,205
| +2% | +$71.5K | ﹤0.01% | 3154 |
|
|
2022
Q3 | $5.05M | Buy |
221,950
+34,689
| +19% | +$789K | ﹤0.01% | 3055 |
|
|
2022
Q2 | $3.38M | Buy |
187,261
+15,679
| +9% | +$283K | ﹤0.01% | 3291 |
|
|
2022
Q1 | $4.59M | Sell |
171,582
-560,138
| -77% | -$15M | ﹤0.01% | 3225 |
|
|
2021
Q4 | $21.5M | Buy |
731,720
+75,697
| +12% | +$2.22M | ﹤0.01% | 2433 |
|
|
2021
Q3 | $43.1M | Buy |
656,023
+69,185
| +12% | +$4.55M | ﹤0.01% | 1912 |
|
|
2021
Q2 | $48.8M | Sell |
586,838
-100,377
| -15% | -$8.35M | ﹤0.01% | 1864 |
|
|
2021
Q1 | $52.7M | Buy |
687,215
+142,642
| +26% | +$10.9M | ﹤0.01% | 1713 |
|
|
2020
Q4 | $48.1M | Buy |
544,573
+215,407
| +65% | +$19M | ﹤0.01% | 1657 |
|
|
2020
Q3 | $24.3M | Buy |
329,166
+23,050
| +8% | +$1.7M | ﹤0.01% | 1913 |
|
|
2020
Q2 | $22.3M | Buy |
306,116
+219,303
| +253% | +$16M | ﹤0.01% | 1962 |
|
|
2020
Q1 | $4.88M | Buy |
86,813
+32,038
| +58% | +$1.8M | ﹤0.01% | 2641 |
|
|
2019
Q4 | $2.09M | Buy |
+54,775
| New | +$2.09M | ﹤0.01% | 3234 |
|